Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Reviva Pharmaceuticals Holdings, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +2 vs. Q4 2021
- Shares held
- 1.90M
- −710.9K (−27.2%) vs. Q4 2021
- Total value
- $4.68M
- −$2.87M (−38.0%) vs. Q4 2021
- New holders
- 4
- 4 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $3.67K |
| Q1 2026 | 35 | $2.13M |
| Q4 2025 | 48 | $3.17M |
| Q3 2025 | 42 | $3.52M |
| Q2 2025 | 46 | $5.44M |
| Q1 2025 | 49 | $6.95M |
| Q4 2024 | 42 | $14.0M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 31 | $8.75M |
| Q1 2024 | 28 | $21.0M |
| Q4 2023 | 36 | $27.1M |
| Q3 2023 | 24 | $13.0M |
| Q2 2023 | 23 | $15.5M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 23 | $5.54M |
| Q3 2022 | 19 | $1.65M |
| Q2 2022 | 13 | $2.05M |
| Q1 2022 | 16 | $4.68M |
| Q4 2021 | 14 | $7.54M |
| Q3 2021 | 12 | $10.5M |
| Q2 2021 | 12 | $12.8M |
| Q1 2021 | 8 | $3.37M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Reviva Pharmaceuticals Holdings, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 1,200,000 | $2.95M | 0.60% | 00.0% | Unchanged |
| Vanguard Group Inc | 465,508 | $1.15M | 0.00% | −28,900−5.8% | Reduced |
| Geode Capital Management, LLC | 78,075 | $192.0K | 0.00% | +1,111+1.4% | Added |
| EMC Capital Management | 55,078 | $135.0K | 0.10% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 31,303 | $77.0K | 0.00% | +2,930+10.3% | Added |
| BlackRock Inc. | 22,842 | $56.0K | 0.00% | −1,994−8.0% | Reduced |
| Raymond James & Associates | 14,000 | $34.0K | 0.00% | +14,000 | New |
| Renaissance Technologies LLC | 12,700 | $31.0K | 0.00% | +12,700 | New |
| Northern Trust Corp | 10,584 | $26.0K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 9,299 | $23.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,346 | $3.00K | 0.00% | +1,346 | New |
| Tower Research Capital LLC (TRC) | 440 | $1.00K | 0.00% | −3,386−88.5% | Reduced |
| Wolverine Asset Management LLC | 659 | $1.00K | 0.00% | +482+272.3% | Added |
| JPMorgan Chase & Co | 347 | $1.00K | 0.00% | +347 | New |
| Bank of America Corp | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 102 | $0 | 0.00% | +5+5.2% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −707,578−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,964−100.0% | Sold out |